These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 8619736)

  • 1. Interference with anticoagulation monitoring by procainamide-induced lupus anticoagulant.
    Metzdorff MT; Hanses KS; Wright GL; Fried SJ
    Ann Thorac Surg; 1996 Mar; 61(3):994-5. PubMed ID: 8619736
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Procainamide-induced lupus anticoagulant.
    Heyman MR; Flores RH; Edelman BB; Carliner NH
    South Med J; 1988 Jul; 81(7):934-6. PubMed ID: 3134699
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Procainamide-induced lupus in a patient with bilateral pleural effusion].
    Ohtani Y; Sumi Y; Hisauchi K; Sawada M; Miyake S; Yamashita Y; Mitunaga K; Yoshizawa Y
    Nihon Kokyuki Gakkai Zasshi; 1998 Jun; 36(6):535-40. PubMed ID: 9754005
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Unusual case of antiphospholipid antibody syndrome presenting with extensive cutaneous infarcts in a patient on long-term procainamide therapy.
    El-Rayes BF; Edelstein M
    Am J Hematol; 2003 Feb; 72(2):154. PubMed ID: 12555226
    [No Abstract]   [Full Text] [Related]  

  • 5. Anticoagulation during cardiopulmonary bypass in patients with heparin-induced thrombocytopenia type II and renal impairment using heparin and the platelet glycoprotein IIb-IIIa antagonist tirofiban.
    Koster A; Kukucka M; Bach F; Meyer O; Fischer T; Mertzlufft F; Loebe M; Hetzer R; Kuppe H
    Anesthesiology; 2001 Feb; 94(2):245-51. PubMed ID: 11176088
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Thrombosis associated with procainamide-induced lupus anticoagulant.
    List AF; Doll DC
    Acta Haematol; 1989; 82(1):50-2. PubMed ID: 2505475
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The impact of heparin concentration and activated clotting time monitoring on blood conservation. A prospective, randomized evaluation in patients undergoing cardiac operation.
    Despotis GJ; Joist JH; Hogue CW; Alsoufiev A; Kater K; Goodnough LT; Santoro SA; Spitznagel E; Rosenblum M; Lappas DG
    J Thorac Cardiovasc Surg; 1995 Jul; 110(1):46-54. PubMed ID: 7609568
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Monitoring of anticoagulation in aprotinin-treated patients during heart operation.
    Tabuchi N; Njo TL; Tigchelaar I; Huyzen RJ; Boonstra PW; van Oeveren W
    Ann Thorac Surg; 1994 Sep; 58(3):774-7. PubMed ID: 7524456
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Studies on a circulating anticoagulant in procainamide-induced lupus erythematosus.
    Edwards RL; Rick ME; Wakem CJ
    Arch Intern Med; 1981 Nov; 141(12):1688-90. PubMed ID: 6171218
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Procainamide-induced circulating anticoagulants in a congenitally-deficient factor XI patient.
    Clyne LP; Farber LR; Chopyk RL
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1989; 116(2):239-44. PubMed ID: 2475403
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The influence of preoperative anticoagulation on heparin response during cardiopulmonary bypass.
    Dietrich W; Spannagl M; Schramm W; Vogt W; Barankay A; Richter JA
    J Thorac Cardiovasc Surg; 1991 Oct; 102(4):505-14. PubMed ID: 1833592
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Simultaneous procainamide-induced immune thrombocytopenia and lupus anticoagulant.
    Freeman NJ; Fajardo L; Carvalho A
    Am J Hematol; 1995 Feb; 48(2):133-4. PubMed ID: 7847333
    [No Abstract]   [Full Text] [Related]  

  • 13. Procainamide-induced lupus anticoagulants and thrombosis.
    Li GC; Greenberg CS; Currie MS
    South Med J; 1988 Feb; 81(2):262-4. PubMed ID: 3124275
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Procainamide induced lupus anticoagulant.
    Weber MT; Hocking WG
    Wis Med J; 1988 Sep; 87(9):30-2. PubMed ID: 3142154
    [No Abstract]   [Full Text] [Related]  

  • 15. Lupus anticoagulant, antiphospholipid syndrome and cardiac surgery.
    Cartwright BL; Bean M; Cooper JO
    Anaesth Intensive Care; 2010 Mar; 38(2):364-9. PubMed ID: 20369774
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lupus anticoagulant and off-pump coronary bypass: dilemma of anticoagulation.
    Maddali MM; Albahrani MJ
    Asian Cardiovasc Thorac Ann; 2007 Jun; 15(3):246-8. PubMed ID: 17540998
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Rapid development of drug-induced lupus nephritis in the absence of extrarenal disease in a patient receiving procainamide.
    McLaughlin K; Gholoum B; Guiraudon C; Jevnikar A; Muirhead N
    Am J Kidney Dis; 1998 Oct; 32(4):698-702. PubMed ID: 9774137
    [No Abstract]   [Full Text] [Related]  

  • 18. Procainamide-induced postoperative pyrexia.
    Murray KD; Vlasnik JJ
    Ann Thorac Surg; 1999 Sep; 68(3):1072-4. PubMed ID: 10510015
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Management of anticoagulation during cardiopulmonary bypass in a patient with a circulating lupus anticoagulant.
    Ducart AR; Collard EL; Osselaer JC; Broka SM; Eucher PM; Joucken KL
    J Cardiothorac Vasc Anesth; 1997 Dec; 11(7):878-9. PubMed ID: 9412889
    [No Abstract]   [Full Text] [Related]  

  • 20. Monitoring of r-hirudin anticoagulation during cardiopulmonary bypass--assessment of the whole blood ecarin clotting time.
    Pötzsch B; Madlener K; Seelig C; Riess CF; Greinacher A; Müller-Berghaus G
    Thromb Haemost; 1997 May; 77(5):920-5. PubMed ID: 9184403
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.